WHAT IS CHEMOTHERAPY INDUCED HAIR LOSS?
Hair loss from chemotherapy is very common, affecting around 60–70% of patients undergoing treatment. It typically begins shortly after chemotherapy starts, with the most noticeable shedding occurring within 2–4 weeks. Hair loss often involves the temples, crown, and back of the head—areas that experience more friction. The primary cause is anagen effluvium (loss of hair during the growth phase), although telogen effluvium can also contribute.
For most patients, hair regrows within 3 months after chemotherapy ends, usually reaching a cosmetically acceptable appearance within 6 months. However, a small percentage experience persistent chemotherapy-induced alopecia (PCIA)—hair loss that lasts more than six months after treatment completion.
WHAT CAUSES PERISTENT CHEMOTHERPAY INDUCED ALOPECIA( PCIA)?
Certain chemotherapy drugs are more strongly linked to persistent chemotherapy-induced alopecia (PCIA). These include:
- Taxanes (docetaxel, paclitaxel) – commonly used in breast cancer treatment
- Busulfan – used for acute myelogenous leukemia
- Cisplatin – used for lung and other cancers
- Etoposide – used for various cancers
- Cyclophosphamide
- Thiotepa
In these cases, hair loss may be permanent because the drugs are thought to cause lasting damage to the stem cells or growth cells within the hair follicle.
WHAT DO INDIVIDUALS WITH PCIA NOTICE ABOUT THEIR HAIR?
Patients with PCIA experience hair loss during chemotherapy, but unlike most cases, hair loss does not fully regrow within the expected 3-6 months after stopping treatment. Instead, the patient only experiences partial regrowth. Scalp hair does not grow long but it remains short, and thinning may be more noticeable in the front of the scalp than at the back.
ARE BLOOD TESTS OR BIOPSY NEEDED?
There are many conditions that can mimic PCIA, so a thorough evaluation is essential. Our expert trichologist Donia Maria Messeh will assess whether another hair loss condition may better explain your symptoms.
Blood tests may be recommended, and in some cases, a scalp biopsy may be needed to confirm the diagnosis.
WHAT TREATMENT OPTIONS ARE AVAILABLE?
Because hair loss in PCIA is permanent, treatment focuses on improving the density and appearance of the remaining hair. Topical or oral minoxidil is often recommended to stimulate growth of existing hair follicles. Other supportive or regenerative treatments may also be advised depending on your individual needs.
At the clinic, each treatment plan is meticulously tailored based on the extent of hair loss, age, medical history, and personal goals. Advanced diagnostic assessments are used to identify potential contributing factors.
DNA testing may also be included, offering valuable insights into each individual’s unique genetic profile and allowing for the creation of truly bespoke, highly effective treatment strategies.
Every consultation begins with a thorough evaluation, not only of your hair and scalp but of your lifestyle, medical history, current routines, and emotional wellbeing. We take the time to listen and uncover the underlying triggers, whether immunological, genetics, hormonal, or environmental.
From there, we design a tailored treatment strategy that may include advanced therapies, topical and systemic interventions, and supportive care.
WHAT ARE MY NEXT STEPS?
Book a consultation with trichologist Donia Maria Messeh, who will evaluate your condition and offer treatment options going forward. Click the link below to start the process.